Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-12

FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for calcipotriene and betamethasone dipropionate topical by Prasco Laboratories, authorizing a supplemental NDA to marke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene and betamethasone dipropionate topical (calcipotriene and betamethasone dipropionate)

Snippet

SUPPL AP for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)